The advantages of a medicated plaster containing betamethasone valerate 0,1% in psoriasis treatment are becoming more and more evident. In depth discussions, benchmark results and clinical cases have been the focus of the symposium "New Opening for Psoriasis Management in 2013", sponsored by IBSA / Genevrier, during the 4th Congress of the Psoriasis International Network, held in Paris from the 4th to the 6th of July 2013. Thanks to this state of the art medicated plaster, the patient will be able to treat the lesion in a fuss-free and functional way, also avoiding the risks of corticosteroid over-dosage which can easily occur when using corticosteroids contained in traditional formulations. Full patient compliance is also guaranteed thanks to an important technological innovation which releases the active ingredient throughout the 24h of application.
The advantages of a medicated plaster containing betamethasone valerate 0,1% in psoriasis treatment are becoming more and more evident. In depth discussions, benchmark results and clinical cases have been the focus of the symposium "New Opening for Psoriasis Management in 2013", sponsored by IBSA / Genevrier, during the 4th Congress of the Psoriasis International Network, held in Paris from the 4th to the 6th of July 2013. Thanks to this state of the art medicated plaster, the patient will be able to treat the lesion in a fuss-free and functional way, also avoiding the risks of corticosteroid over-dosage which can easily occur when using corticosteroids contained in traditional formulations. Full patient compliance is also guaranteed thanks to an important technological innovation which releases the active ingredient throughout the 24h of application.
relazioni
Prof. Luigi Naldi - Opening speech
Koebner phenomenon in psoriasis management - Part 1
Koebner phenomenon in psoriasis management - Part 2
Koebner phenomenon in psoriasis management - Part 3
BMV Plaster improved efficacy & advantages - Part 1
BMV Plaster improved efficacy & advantages - Part 2
BMV Plaster improved efficacy & advantages - Part 3
BMV Plaster improved efficacy & advantages - Part I
BMV Plaster improved efficacy & advantages - Part II
New Opening for Psoriasis Management 2013 - Discussion
Discussion - The opinion of a patient, Mara Maccarone
casi clinici
BMV Plaster - Case 1
BMV Plaster - Case 2
BMV Plaster - Case 3
BMV Plaster - Case 4
BMV Plaster - Case 5
